Generic Drug Analysis & Statistics in Netherlands, June 2013

» Purchase Premium Reports

1-3 of 3 reports

ratiopharm Generics Company Intelligence Report

$ 341
Company report
January 2011
by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

Industries : Generic Drug
Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom

Actavis Generics Company Intelligence Report

$ 341
Company report
January 2011
by Espicom Business Intelligence

Industries : Generic Drug
Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America

Biosimilars: A viable market - but when?

$ 2 755
Industry report
September 2008
by Espicom Business Intelligence

Providing? A thorough review of the latest regulatory situation in the USA, Europe and selected markets An examination of products that are currently available for development: - EPO - HGH - G-CSF ...

Industries : Generic Drug, Biotechnology
Countries : United States, France, Europe, Netherlands

» Download Public Reports

3 reports

Navamedic ASA - Forward Looking Presentation for Year 2011

Company report
March 2011
15 pages

... Attractive than previously anticipated. Navamedic has succeeded in building a broad pipeline of new generic drugs as well as original products with expired patents. At the same time, the company S two ...

Investor Presentation: Generic Drug In Netherlands And Finland Fo ...

March 2011

Investor Presentation: Generic Drug In Netherlands For Year 2011

March 2011

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.